| Document Date: 2009-11-23 11:14:48
Open Document File Size: 90,86 KBShare Result on Facebook
City Melville / / Company E. FOUGERA & CO. / Nycomed US Inc. / / Event Product Issues / Product Recall / / Facility Laboratory Tests / / IndustryTerm corticosteroid-containing products / corticosteroid-containing product / / MedicalCondition intracranial hypertension / inflammatory and pruritic manifestations / allergic contact dermatitis / cleft palates / headaches / atopic dermatitis / telangiectasia / Urinary free cortisol test ACTH stimulation test Carcinogenesis / disease / hyperglycemia / folliculitis / umbilical hernias / hypopigmentation / acneiform eruptions / itching / secondary infection / Chronic corticosteroid therapy / bilateral papilledema / corticosteroid-responsive dermatoses / miliaria / dermatological infections / each disease / disorder / perioral dermatitis / psoriasis / hypertrichosis / irritation / infection / Inflammation / fetal resorption / syndrome / / Organization DOSAGE AND ADMINISTRATION / / Position physician / General / / Product cosyntropin / drug / prednisolone / dexamethasone / sorbitol / ACTH / BETAMETHASONE DIPROPIONATE / hydrocortisone / / ProvinceOrState Newfoundland / New York / / Technology Pharmacokinetics / /
SocialTag |
BETAMETHASONE DIPROPIONATE CREAM USP (AUGMENTED*), 0.05% (potency expressed as betamethasone) * Vehicle augments the penetration of the steroid. FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE